What if you invested in Gilead Sciences in 2000?
GILD · Healthcare · Data through 2026-06-01
If you invested $1,000 in Gilead Sciences in 2000
The same $1,000 in the S&P 500 would be worth $8,517(+751.7%)
The S&P 500 returned $8,517 on the same $1,000. Gilead Sciences beat the market by $116,497.
Try a different start date
Pick any month and year to see what Gilead Sciences would be worth.
Compare Gilead Sciences to another stock
See how Gilead Sciences stacks up since 2000, head to head.
What if Gilead Sciences keeps this up?
Project forward at Gilead Sciences's 19.9% historical growth rate. See 5-30 year scenarios.
Growth of $1,000
Gilead Sciences vs. S&P 500 vs. US Dollar, 2000 to present
Year-by-Year Returns
$1,000 invested in Gilead Sciences starting January 2000
| Year | Price | Value | Annual |
|---|---|---|---|
| 2000 | $1.00 | $1,000 | - |
| 2001 | $1.45 | $1,446 | +44.6% |
| 2002 | $2.81 | $2,795 | +93.3% |
| 2003 | $2.99 | $2,982 | +6.7% |
| 2004 | $4.70 | $4,683 | +57% |
| 2005 | $5.68 | $5,657 | +20.8% |
| 2006 | $10.44 | $10,402 | +83.9% |
| 2007 | $11.04 | $10,992 | +5.7% |
| 2008 | $15.68 | $15,616 | +42.1% |
| 2009 | $17.42 | $17,353 | +11.1% |
| 2010 | $16.56 | $16,498 | -4.9% |
| 2011 | $13.17 | $13,118 | -20.5% |
| 2012 | $16.77 | $16,700 | +27.3% |
| 2013 | $27.08 | $26,967 | +61.5% |
| 2014 | $55.35 | $55,131 | +104.4% |
| 2015 | $71.95 | $71,659 | +30% |
| 2016 | $57.64 | $57,414 | -19.9% |
| 2017 | $51.48 | $51,276 | -10.7% |
| 2018 | $61.28 | $61,037 | +19% |
| 2019 | $52.82 | $52,610 | -13.8% |
| 2020 | $49.52 | $49,319 | -6.3% |
| 2021 | $53.48 | $53,271 | +8% |
| 2022 | $58.39 | $58,154 | +9.2% |
| 2023 | $74.62 | $74,319 | +27.8% |
| 2024 | $72.25 | $71,966 | -3.2% |
| 2025 | $93.41 | $93,036 | +29.3% |
| 2026 | $140.23 | $139,667 | +50.1% |
What this return means
$1,000 put into Gilead Sciences (GILD) in 2000 turned into $125,014. That is a +12,401% total return, or roughly 125x your money, measured through 2026-06-01.
In compound terms that is roughly 19.9% a year, well above what a broad index has historically returned. The same $1,000 in an S&P 500 index fund over the same span would be about $8,517, so Gilead Sciences beat the index by roughly $116,497. The index compounded at about 8.4% a year over that period.
Getting here meant sitting through real volatility. The best single year was 2014 at +104.4%, and the worst was 2011 at -20.5%. At its lowest point the position was down about 31% from an earlier high. These figures use split-adjusted closing prices and exclude dividends, taxes, trading fees, and inflation, so a real after-tax result would differ.
This is historical math, not financial advice. Past performance does not guarantee future results.
What if you invested $100 a month instead?
Most people do not drop a lump sum in on day one. They add a fixed amount every month. Putting $100 into Gilead Sciences at the close of every month from January 2000 through June 2026 means 318 buys and $31,800 contributed over about 26.5 years.
$100/month, dollar-cost averaged
$413,525
+1,200.4% on $31,800 in
Same $31,800, all in at the start
$3,991,536
+12,452% on $31,800 in
Going all in at the start beat spreading the buys out by $3,578,011. That is the usual result when a stock trends up: each monthly buy pays a higher price than the last, so the average cost climbs. Averaging in also meant an average buy price of $9.65 per share across the whole stretch, so the monthly buyer never had to time a single low. Neither number counts dividends, taxes, or trading costs.
Illustrative fixed $100/month example, not a recommendation. Figures are computed from GILD split-adjusted monthly closes through June 2026. Past performance does not guarantee future results.
Gilead Sciences at different times
See how the start year changes the outcome
More Healthcare investments
Compare returns across the sector
Related reading
Deep dives and analysis
Numbers worth sharing
Occasional data drops when something interesting surfaces. No schedule, just signal.
For informational and educational purposes only. Not financial advice. Past performance does not guarantee future results. All calculations are based on split-adjusted closing prices from Yahoo Finance and do not account for dividends, taxes, or trading fees. See our methodology and full disclaimer.